Patents by Inventor Jouko Vepsäläinen

Jouko Vepsäläinen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11796470
    Abstract: The present disclosure relates to a method for detecting a prostate cancer related biomarker, including contacting the diluted sample with a modulating agent selected from a group consisting of sodium; 3-hydroxy-4-[(2-hydroxynaphthalen-1-yl)diazenyl]naphthalene-1-sulfonate, sodium; 3-hydroxy-4-[(1-hydroxynaphthalen-2-yl)diazenyl]-7-nitronaphthalene-1-sulfonate, triisopropylsilane, and iron(III) chloride, and a luminescent label to obtain a measurement sample. Then, the measurement sample is incubated for a period of time and excited thereafter. Time-resolved luminescence signal of the label in the measurement sample is measured, leading to an increased likelihood of prostate cancer of the human subject if the luminescence signal is at least 50% higher than for a control sample from a human subject without prostate cancer.
    Type: Grant
    Filed: May 4, 2021
    Date of Patent: October 24, 2023
    Assignee: Aqsens Health Oy
    Inventors: Janne Kulpakko, Jouko Vepsäläinen, Susanna Paavilainen
  • Publication number: 20230235245
    Abstract: The invention relates to a method for processing black liquor soap, particularly to a method for producing and recovering fatty acid esters and resin acids from black liquor soap. The method is based on a catalytic selective esterification of the soap.
    Type: Application
    Filed: June 24, 2021
    Publication date: July 27, 2023
    Inventors: Olavi RAATIKAINEN, Petro SUVANTO, Jouko VEPSÄLÄINEN, Jukka LEPPÄNEN, Petri TURHANEN
  • Publication number: 20210372989
    Abstract: The present disclosure relates to a method for detecting a prostate cancer related biomarker, including contacting the diluted sample with a modulating agent selected from a group consisting of sodium; 3-hydroxy-4-[(2-hydroxynaphthalen-1-yl)diazenyl]naphthalene-1-sulfonate, sodium; 3-hydroxy-4-[(1-hydroxynaphthalen-2-yl)diazenyl]-7-nitronaphthalene-1-sulfonate, triisopropylsilane, and iron(III) chloride, and a luminescent label to obtain a measurement sample. Then, the measurement sample is incubated for a period of time and excited thereafter. Time-resolved luminescence signal of the label in the measurement sample is measured, leading to an increased likelihood of prostate cancer of the human subject if the luminescence signal is at least 50% higher than for a control sample from a human subject without prostate cancer.
    Type: Application
    Filed: May 4, 2021
    Publication date: December 2, 2021
    Applicant: Aqsens Health Oy
    Inventors: Janne Kulpakko, Jouko Vepsäläinen, Susanna Paavilainen
  • Publication number: 20190084857
    Abstract: The present invention relates to a water treatment method for removing sulfur substances using a solid material comprising 2-amino-2-deoxy-d-glucopyranose structural units, wherein the solid material is combined with an acidic aqueous medium containing sulfur substances so that the negatively charged sulfur substances can be bound to the solid material and subsequently be removed from the aqueous medium by separating the solid material. The present invention can be used to remove sulfur substances such as sulfate, bisulfate, sulfite, bisulfite, metabisulfite, sulfide, bisulfide and thiosulfate from an aqueous medium.
    Type: Application
    Filed: August 28, 2016
    Publication date: March 21, 2019
    Inventors: Juha-Matti Aalto, Janne Kankkunen, Jouko Vepsäläinen
  • Patent number: 7202280
    Abstract: Novel methods for treating and preventing acute and/or chronic pancreatitis are described. Additionally, novel methods for inducing liver regeneration are described. The methods may comprise administering to a patient an effective amount of a metabolically stable analogue of spermidine and/or spermine. Preferred compounds for use in the methods may include 1-methylspermidine, 1-methylspermine and 1,12-dimethylspermine.
    Type: Grant
    Filed: December 9, 2003
    Date of Patent: April 10, 2007
    Inventors: Tiina-Liisa Räsänen, Leena Alhonen, Riitta Sinervirta, Tuomo Keinänen, Karl-Heinz Herzig, Alex Radii Khomutov, Jouko Vepsäläinen, Juhani Jänne
  • Patent number: 6326363
    Abstract: The object of the invention are novel halogen substituted methylenebisphosphonic acid anhydrides, ester anhydrides, amide anhydrides, and ester amide anhydrides, processes for the preparation of these novel compounds, as well as pharmaceutical preparations comprising these novel compounds.
    Type: Grant
    Filed: July 12, 2000
    Date of Patent: December 4, 2001
    Assignee: Leiras Oy
    Inventors: Esko Pohjala, Heikki Nupponen, Leena Laurén, Ritva Hannuniemi, Jouko Vepsäläinen, Jouni Kähkönen, Tomi Järvinen, Marko Ahlmark